Research field (3):
Immunology
, Physiology
, Clinical pharmacy
Research theme for competitive and other funds (7):
2019 - 2022 The development of Intravenous lipid emulsion therapy for overdoses of lipophilic drugs
2017 - 2019 Basic research on new therapeutic strategy for rheumatoid arthritis to induction of immune tolerance
2015 - 2018 Development of methods for reducing venous pain caused by dacarbazine
2014 - 2016 Development of novel therapy for intractable dermatitis using immunomodulator FTY720 (fingolimod) ointment
2012 - 2014 Development of oral therapy for type 1 diabetes mellitus
2007 - 2008 A novel immunomodulator, FTY720, ameliorates spontaneous dermatitis in NC/Nga mice
2007 - 1型糖尿病に対する新しい治療戦略の開発
Show all
Papers (49):
Shohei Nakano, Norihisa Mikami, Mai Miyawaki, Saho Yamasaki, Shoko Miyamoto, Mayu Yamada, Tomoya Temma, Yousuke Nishi, Arata Nagaike, Seijun Sakae, et al. Therapeutic Strategy for Rheumatoid Arthritis by Induction of Myeloid-Derived Suppressor Cells with High Suppressive Potential. Biol. Pharm. Bull. 2022. 45. 8. 1053-1060
Tsuji, T., Hosoda, A., Toriyama, Y., Yoshida, Y., Kohno, T. Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice. TRANSLATIONAL ONCOLOGY. 2022
Yoneda, K., Fujii, M., Imaoka, A., Kobayashi, R., Hayashi R., Yoshida, et al. Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia. Support Care Cancer. 2021. 29. 10. 6127-6134
Yoneda, K, Fujii, M, Imaoka, A, Kobayashi, R, Hayashi R, Yoshida, Y, Kohno, T, Tsuji, T. Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia. Support Care Cancer. 2021. 29. 10. 6127-6134